The lupus anticoagulant is rarely associated with bleeding but can coexist with a specific Factor VIII inhibitor.
What does FVIII stand for?
FVIII stands for Factor VIII (blood clotting)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Forage Value Index (agriculture)
- Force de Vente Informatique (French: Computing Sales Force)
- Foreign Vessel Inspection
- France Vétérinaire International (French: France International Veterinary)
- France Volet Intex (French finance company)
- Fruta Vida International (est. 2004; Alabama)
- Frequency of Visibly Infected Cells
- Future Value Interest Factor
- Future Value Interest Factor for an Annuity
- Fortune Venture Investment Group (capital fund management)
- Firm Value Increase Measure
- Fox Valley Internal Medicine, LLC (Crystal Lake, IL)
- Family Violence Intervention Program (Florida)
- First Virtual Internet Payment System
- Flammable Vapor Ignition Resistance
- Federation of Vehicle Industry Unions
- Foreign Volunteers Japan (Japon)
- Fortescue Metals Group Ltd. (Australia)
- Freddy vs Jason (movie)
- Fountain Valley Jr All American Football (California)
Samples in periodicals archive:
Hemophilia A is an inherited blood clotting disorder caused by a mutation in the factor VIII gene resulting in a deficiency of factor VIII protein.
Previously approved for preventing and controlling bleeding in patients with factor VIII deficiency due to hemophilia A or acquired factor VIII deficiency.
The facility makes recombinant Factor VIII therapy, basically a therapeutic protein that enables people with the blood-clotting disorder to lead nearly normal lives.
Factor VIII is essential to prevent bleeding in patients with haemophilia but contaminated stocks have led to hundreds of patients being infected with the Aids virus and hepatitis viruses.
We investigated whether CSS-prepared material is substantially equivalent in factor VIII and fibrinogen contents to the traditionally prepared Cryo material.
Factor VIII account for a major portion of plasma-derived clotting factor and lack of which causes Hemophilia A.
Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.